Lupin shines on reporting 56% rise in Q1 net profit

30 Jul 2014 Evaluate

Lupin is currently trading at Rs 1187.00, up by 68.30 points or 6.11% from its previous closing of Rs 1118.70 on the BSE.

The scrip opened at Rs 1125.00 and has touched a high and low of Rs 1192.10 and Rs. 1113.20 respectively. So far 324645 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 1139.00 on 28-Jul-2014 and a 52 week low of Rs. 742.30 on 28-Aug-2013.

Last one week high and low of the scrip stood at Rs 1139.00 and Rs 1078.00 respectively. The current market cap of the company is Rs 52615.24 crore.

The promoters holding in the company stood at 46.73% while Institutions and Non-Institutions held 42.72% and 10.55% respectively.

Lupin has reported results for first quarter ended June 30, 2014.

The company’s net profit from ordinary activities after tax for the quarter surged 55.77% at Rs 624.74 crore as compared to Rs 401.06 crore for the quarter ended June 30, 2013. Its total income has increased by 30.75% to Rs 3369.73 crore for the quarter under review from Rs 2577.11 crore for the corresponding quarter of the previous year.

Lupin is an innovation led transnational pharmaceutical company producing and developing a wide range of branded and generic formulations and APIs globally.

 

Lupin Share Price

2139.40 -26.70 (-1.23%)
21-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1612.55
Dr. Reddys Lab 1155.50
Cipla 1369.55
Zydus Lifesciences 876.10
Lupin 2139.40
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×